Monday, October 19, 2026

WD #360: New Trade, Recent Market Action, Brazil/Inter Update

Atlassian is sold after a 130% gain, while iShares MSCI Indonesia ETF is added following the market plunge; the update also assesses the AI-stock selloff and CoreWeave’s collapse.

TEAM $56B

Ian’s Insider Corner 39h ago 14 clicks

43h ago NOC $73B

Northrop Grumman (NYSE: NOC) Q3 FY12/26 Earnings Preview - Accumulate Rating, Zones And Stop Inside

Cestrian Capital Research 4 clicks

45h ago APP $92B

AppLovin Deep Dive

Speedwell Memos 64 clicks

From X

@DeepSailCapital 35h ago

Deep Sail Capital on X

$ARKK is an excellent alternative hedge short IMO to QQQ. A bit of timing to avoid the massive bubbles but way more follow through to the downside. https://t.co/jyUYhlMit4

@DeepSailCapital 36h ago 5 clicks

Deep Sail Capital on X

$ARKK vs $SPY vs $QQQ by year. https://t.co/XEaaaCTQvL

@Mr_Neutral_Man 37h ago 2 clicks

Mr Neutral Man aka "Howard Marks of REITs” on X

@Menckenist @rippercatcher Very interesting. What's the typical mix of a $WD loan? Is it moslty fixed rate with 5-7 year maturity? How much of it is the type that finance the S2 and Tide capital where deals were done at 3% cap with floating rate debt greatly appreciate this!

@BarbarianCap 38h ago

Barbarian Capital on X

Silgan to Combine With Trivium Packaging in $3.4 Billion Deal $SLGN https://t.co/XWQSkZuUO5

@BarbarianCap 38h ago

Barbarian Capital on X

Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion $SLN https://t.co/FXr0mtRMow

@BarbarianCap 38h ago 2 clicks

Barbarian Capital on X

H.B. Fuller Rejects Ancora’s Latest Acquisition Bid, Plans to Consider Selling Noncore Businesses $FUL https://t.co/L8b85qb666

@BarbarianCap 38h ago 6 clicks

Barbarian Capital on X

Unilever Agrees to Sell Welly Bandage Business to Private-Equity Firm $UL https://t.co/yFW742mFrr

@StableBread 38h ago

Fajasy on X

From June 1 to October 16, Boost Run $BRUN fell 77.3%, vs. 37.4-58.7% for CoreWeave $CRWV, Nebius $NBIS, and $IREN. That drop in AI infra stocks is tied to to rising bets on another Fed rate hike. Higher rates hurt GPU clouds in two ways, since they (1) raise the cost of the debt that pays for their GPUs and (2) lower what investors will pay today for profits that arrive years later. But all three peers kept or raised their 2026 targets: → $CRWV: Raised its 2026 revenue guidance to $12.4-13.2B on its Q2 call. → $IREN: Raised its year-end ARR target to more than $4B on July 20. → $NBIS: Reaffirmed its 2026 guidance with its Q2 results. The problem is that lenders are charging more now. CoreWeave’s 9.625% notes due 2032 yielded 14.74% on October 16, up from 13.19% on October 1, meaning CoreWeave would likely pay ~15%/year to borrow the same way today. So the selloff came from how investors now see the cost of funding the demand for GPU clouds, not from the demand itself.

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $525M

Trade Ideas Flow Oct 19 20 clicks

Sell Eagle Point Credit Now - Match The Loss With Portfolio Gains To Lower Income Taxes

Eagle Point Credit's NAV is down 25% YTD and shares nearly 50%, while its expense ratio climbed to 9.21% despite a 25% yield.

ECC $379M

Anthony Cataldo Oct 19 5 clicks

The Agentic AI Roadmap for SaaS

SaaS companies including Salesforce, ServiceNow, CrowdStrike, Synopsys and Veeva are ranked by agentic AI progress, from pilots to…

CRM $197BCRWD $233B

Jimmy's Journal Oct 19 26 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M

TSOH Investment Research Oct 19 17 clicks

The Monday Morning Briefing: Meta, Tesla, Netflix, P&G on Deck

Lennar’s land-bank costs pressure homebuilding margins, while Flowers Foods weighs a Tastykake sale after falling branded-bread share,…

LEN $18BFLO $1.3B

Latticework by MOI Global Oct 19 34 clicks

LendingTree (NASDAQ: $TREE) – A Cyclical Comeback Story Priced as if the Cycle Never Turns

LendingTree derives roughly two-thirds of revenue from insurance and trades near 4 times expected adjusted earnings despite record revenue,…

TREE $362M

Substack von Philipp Oct 19 10 clicks

Our Q3 2026 Update: Our Companies (OXY, RIG, VAL)

Occidental Petroleum’s debt should fall further after Q3 oil prices averaged $85 per barrel WTI and $91 Brent.

OXY $63BRIG $6.5B

Open Insights Oct 19 14 clicks

40 Stock Pitches (12th-18th October) 🖨️

Elutia’s antibiotic-eluting surgical matrices target breast-surgery infections, with Minot Light valuing $100 million in sales at a…

ELUT $36M

Capital Employed Oct 19 65 clicks

Undercovered Dozen: Hess Midstream, Iovance Biotherapeutics, Netlist, And More

Hess Midstream, Iovance Biotherapeutics, Netlist and nine other lesser-covered stocks make this week’s Undercovered Dozen.

HESM $6.3BIOVA $6.7B

The Undercovered Dozen Oct 18 15 clicks

Zscaler CEO and CFO: We have the opportunity of a lifetime

Zscaler CEO Jay Chaudhry and CFO Kevin Rubin discuss the cybersecurity company’s growth prospects and valuation.

ZS $34B

The Technology Letter Oct 18 6 clicks

TPLKF · long

PVA Tepla

PVA TePla (XTRA:TPE) is presented as a long position.

TPLKF $742M

Value Investors Club Jun 22 2 clicks

Adobe Investment Case Summary

Adobe investment case summary.

ADBE $98B

Global Outperformers Aug 21

One quote to rule them all

Deere raised net income and cash flow guidance despite a 10% Production and Precision Ag sales decline, as construction and small-ag…

DE $170B

Best Anchor Stocks Aug 21

IRTC 2026-08-21

iRhythm: The Algorithmic Margin Inflection Changes The Story

IRhythm’s ZEUS clearance cuts clinician review time 50%, targeting $100 million in five-year savings as cardiac monitoring margins expand…

IRTC $3.6B

Equity Eagle Aug 21

Research & Analysis: Stabilis Solutions (NASDAQ: SLNG)

Stabilis Solutions lost its Galveston LNG offtake anchor, revenue fell 36% in 1H’26, and limited liquidity leaves its data-center power…

SLNG $86M

Monte Independent Investment Research Aug 21

PLTR 2026-08-21

Palantir: Why Michael Burry's Put Buys Should Not Deter Retail Investors

Palantir's U.S. commercial business grew triple digits as GAAP net margins rose from under 10% to 55%, countering Michael Burry's bearish…

PLTR $482B

Elizabeth Pramila Aug 21 1 click

The Real Brokerage: Transformation (Ticker: REAX)

Real Brokerage’s RE/MAX acquisition would triple its agent count, diversify revenue with franchise fees and expand share during a weak U.S.

REAX $577MRMAX $263M

Emerging Moats Research Aug 21

CORT 2026-08-21

Like The Knick's, Corcept Rebounded And Is Crushing It

Corcept Therapeutics expects Lifyorli and Korlym to support 44% revenue growth, while FDA and European decisions on relacorilant could…

CORT $13B

ChuckJones Aug 21 1 click

$ELAL: El Al is a wartime monopoly at 2x EBITDA. Is that a trap? | ASB Partners

El Al trades near 2x EBITDA after wartime near-monopoly profits, with $1.3 billion of net cash and owned aircraft weighed against…

ELALF $3.5B

Yet Another Value Podcast Aug 20 13 clicks

Moderna: An Atypical Investment with an Asymmetric Payoff

Moderna's Phase 3 intismeran autogene trial met its recurrence-free survival endpoint in adjuvant melanoma, supporting an asymmetric…

MRNA $87B

Bireme Capital - Investor Letters Aug 20 1 click

Monday, October 19, 2026

Deep Sail Capital on X

Deep Sail Capital on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Fajasy on X

Investor Letters

Publications we follow

Newsletters 108

YouTube 4

Blogs 15

Seeking Alpha 52 of 245

X accounts we follow

Investor letters we follow

Sectors